arrow
S

Sneha Ramakrishna

Stanford University
H指数:21
被引数:5,068

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Expert Panel Review and Practical Guidance on Biomarker Testing With Engineered Immune Effector Cells

专家小组评审及工程化免疫效应细胞生物标志物检测的实用指南

2026-05-160
OAAI
Linking HLA-DRB1*15 to Severe Dress-like Inflammatory Toxicities Following Tocilizumab after CAR-T Therapy

将HLA-DRB1*15与托珠单抗治疗后的CAR-T疗法相关严重DRESS样炎症性毒性反应相联系

2026-03-100
PRE
The quintessential role for CAR T cell therapy in children, adolescents and young adults with cancer

CAR T细胞治疗在儿童、青少年和青年癌症患者中的典型作用

2026-01-230
PRE
EVALUATION OF B7-H3 IMMUNOHISTOCHEMISTRY IN HIGH-GRADE GLIOMAS FOR CHIMERIC ANTIGEN RECEPTOR T-CELL PREDICTIVE TESTING

B7-H3免疫组织化学在高级别胶质瘤中用于嵌合抗原受体T细胞预测性检测的评价

2025-11-010
OAAI
HUMANIZED ANTI-CAR ANTIBODIES AFFECT DURABLE RESPONSE TO GD2-CAR T-CELLS IN DIFFUSE MIDLINE GLIOMA

人源化抗CAR抗体影响弥漫性中线胶质瘤中GD2-CAR T细胞的持久应答

2025-11-010
OAAI
SINGLE-CELL LANDSCAPE OF B7H3-CAR T THERAPY IN GLIOMA: MECHANISMS OF RESISTANCE AND SIGNATURES OF LONG-TERM RESPONSE

单细胞景观揭示B7H3-CAR T疗法在胶质瘤中的抗药机制及长期应答特征

2025-11-010
PRE
Outcomes following CD22 CAR T-cells in B-ALL: a tale of two manufacturing strategies

CD22 CAR T细胞在B-ALL中的治疗效果:两种制造策略的故事

2025-10-020
PRE
Intravenous and intracranial GD2-CAR T cells for H3K27M+ diffuse midline gliomas

静脉和颅内GD2-CAR T细胞用于H3K27M弥漫性中线胶质瘤

Nature
IF48.5
2024-11-130
OAAI
MYELOID POPULATIONS MODULATE GD2 CAR T CELL ACTIVITY IN DIFFUSE MIDLINE GLIOMA
2024-11-110
PRE
TUMOR INFLAMMATION-ASSOCIATED NEUROTOXICITY (TIAN): A TOXICITY SYNDROME IN PATIENTS TREATED WITH IMMUNOTHERAPY FOR CENTRAL NERVOUS SYSTEM TUMORS

肿瘤炎症相关神经毒性 (TIAN): 中枢神经系统肿瘤免疫治疗患者的毒性综合征

2024-06-180
OAAI
SEQUENTIAL INTRAVENOUS AND INTRACEREBROVENTRICULAR GD2-CAR T-CELL THERAPY FOR H3K27M-MUTATED DIFFUSE MIDLINE GLIOMAS
2024-06-180
OAAI
CD22 CAR T cells demonstrate high response rates and safety in pediatric and adult B-ALL: Phase 1b results
LEUKEMIA
IF13.4
2024-03-153
OA
TUMOR INFLAMMATION-ASSOCIATED NEUROTOXICITY (TIAN): A TOXICITY SYNDROME IN PATIENTS TREATED WITH IMMUNOTHERAPY FOR CENTRAL NERVOUS SYSTEM TUMORS
2023-06-120
OAAI
Tumor inflammation-associated neurotoxicity

肿瘤炎症相关神经毒性

2023-04-0647
OA
Immune signatures of GD2 CAR T cell activity in H3K27M+diffuse midline glioma patients
2023-04-040
PRE